moclobemide has been researched along with rs 8359 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwata, N; Kumagae, Y; Matsui, Y | 1 |
Plenker, A; PĆ¼chler, K; Volz, HP | 1 |
1 trial(s) available for moclobemide and rs 8359
Article | Year |
---|---|
Safety, tolerability and efficacy of the reversible monoamine oxidase inhibitor RS-8359 in early clinical trials.
Topics: Antidepressive Agents; Benzamides; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Nitriles; Prospective Studies; Pyrimidines | 1997 |
1 other study(ies) available for moclobemide and rs 8359
Article | Year |
---|---|
Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
Topics: Animals; Benzamides; Biogenic Monoamines; Brain; Cerebral Cortex; Clorgyline; Corpus Striatum; Deamination; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitriles; Norepinephrine; Pyrimidines; Rats; Rats, Inbred Strains; Selegiline; Serotonin | 1991 |